Then again, as long as the big pharmaceuticals still have a profit margin of 25% or so I don't think they are the victims here... Point is that there are two si

Then again, as long as the big pharmaceuticals still have a profit margin of 25% or so I don't think they are the victims here... Point is that there are two sides to this coin: the pharmaceuticals charging way too much for their medicine and the Indian companies copy-catting/piggy backing on the US R&D